Abstract:Antiviral defense by type III CRISPR-Cas systems relies on two distinct activities of their effectors: the RNA-activated DNA cleavage and synthesis of cyclic oligoadenylate. Both activities are featured as indiscriminate nucleic acid cleavage and subjected to the spatiotemporal regulation. To yield further insights into the involved mechanisms, we reconstituted LdCsm, a lactobacilli III-A system in Escherichia coli. Upon activation by target RNA, this immune system mediates robust DNA degradation but lacks the synthesis of cyclic oligoadenylates. Mutagenesis of the Csm3 and Cas10 conserved residues revealed that Csm3 and multiple structural domains in Cas10 function in the allosteric regulation to yield an active enzyme. Target RNAs carrying various truncations in the 3' anti-tag were designed and tested for their influence on DNA binding and DNA cleavage of LdCsm. Three distinct states of ternary LdCsm complexes were identified. In particular, binding of target RNAs carrying a single nucleotide in the 3' anti-tag to LdCsm yielded an active LdCsm DNase regardless whether the nucleotide shows a mismatch, as in the cognate target RNA (CTR), or a match, as in the noncognate target RNA (NTR), to the 5' tag of crRNA. In addition, further increasing the number of 3' anti-tag in CTR facilitated the substrate binding and enhanced the substrate degradation whereas doing the same as in NTR gradually decreased the substrate binding and eventually shut off the DNA cleavage by the enzyme. Together, these results provide the mechanistic insights into the allosteric activation and repression of LdCsm enzymes.

Widespread RNA-based cas regulation monitors crRNA abundance and anti-CRISPR proteins

Degenerated CRISPRs widely regulate Cas expression to balance immunity and cost

High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho termination

Allosteric Regulation of Csx1, a Type IIIB-associated CARF Domain Ribonuclease by RNAs Carrying a Tetraadenylate Tail

crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense

Regulating the Trans-Cleavage Activity of CRISPR/Cas12a by Using an Elongation-Caged Single-Stranded DNA Activator and the Biosensing Applications.

CdpR Inhibits CRISPR-Cas Adaptive Immunity to Lower Anti-viral Defense While Avoiding Self-Reactivity.

Reprogrammed Tracrrnas Enable Repurposing of RNAs As Crrnas and Sequence-Specific RNA Biosensors

Progress of CRISPR-based programmable RNA manipulation and detection.

Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

A Redox Switch Regulates the Assembly and Anti-Crispr Activity of AcrIIC1

Target RNA-guided protease activity in type III-E CRISPR–Cas system

Reprogrammed Tracrrnas Enable Repurposing RNAs As Crrnas and Detecting RNAs

Visualization of Type IV-A1 CRISPR-mediated repression of gene expression and plasmid replication

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover

Diversity and abundance of ring nucleases in type III CRISPR-Cas loci

CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.

Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.